Del. health officials advising providers to offer Pfizer boosters to eligible citizens

covid-19 DE

DOVER, Del. – The Delaware Division of Public Health announced on Friday that state vaccine providers can begin administering booster doses of the Pfizer-BioNTech vaccine to certain populations.

On Wednesday, the U.S. Food and Drug Administration formally voted to expand the Emergency Use Authorization to allow for a booster dose of this vaccine to be administered for certain populations six months after receiving the second dose of the Pfizer vaccine.

Boosters have not yet been authorized for those who received the Moderna or Johnson & Johnson vaccines due to the lack of adequate data to support including them.

Based on CDC recommendations, those age 65 years and older and residents in long-term care settings should receive a booster shot at least six months after their second dose of Pfizer. In addition, those age 50 to 64 with underlying medical conditions, including cancer, diabetes, pregnancy, stroke, chronic heart, lung, and kidney diseases, and HIV, should get a booster shot.

The CDC also says that people age 18 to 49 years with underlying medical conditions or are at increased risk for COVID-19 exposure and transmission because of occupational or institutional settings, including healthcare workers, teachers and daycare staff, grocery workers, and those in homeless shelters or prisons.

For a full list of locations where vaccines are available, click here.

Categories: Coronavirus, Delaware, Local News, Top Stories